Available datapackage for study 'A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF A DOSE TITRATION REGIMEN FOR THE SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB IN SUBJECTS WITH OSTEOARTHRITIS OF THE HIP OR KNEE'
Abstract
The primary purpose of this study is to evaluate the efficacy of a titration arm of tanezumab in which treatment is started at a lower dose (2.5 mg) and increased to a higher dose (5 mg) at Week 8, compared to giving 2 doses of tanezumab 2.5 mg or 2 doses of placebo. The study also evaluates the safety of the treatment regimens.
Fields of Study & Subjects
Osteoarthritis Treatment and Mechanisms
Pain Mechanisms and Treatments
Musculoskeletal pain and rehabilitation
Publication details
- Journal / source
- Vivli
- Publication date
- 14 January 2026
- Language
- EN
- Document type
- Dataset